Article

New Workflow Predicts Drug Targets Against SARS-CoV-2 via Metabolic Changes in Infected Cells

2023-01-17

Abstract excerpt

COVID-19 is one of the deadliest respiratory diseases, and its emergence caught the pharmaceutical industry off guard. While vaccines have been rapidly developed, treatment options for infected people remain scarce, and COVID-19 poses a substantial global threat. This study presents a novel workflow to predict robust druggable targets against emerging RNA viruses using metabolic networks and information of the vir...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fca7026d-e624-5b1e-9ca0-9839dbf1a040
DOI: 10.20944/preprints202203.0290.v3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

New Workflow Predicts Drug Targets Against SARS-CoV-2 via Metabolic Changes in Infected CellsDOI 10.20944/preprints202203.0290.v3Read

Genome Scale-Differential Flux Analysis reveals deregulation of lung cell metabolism on SARS Cov2 infectionSemantic proximity Read

Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targetsSemantic proximity Read

Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targetsSemantic proximity Read

Conserved metabolic vulnerabilities across pathogenic coronaviruses nominate host-directed therapeutic targetsSemantic proximity Read

Inhibiting the reproduction of COVID-19-causing SARS-CoV-2 through perturbations in human cell metabolic networkSemantic proximity Read

A target prediction method to inhibit the replication process of SARS-CoV-2 via metabolic differential analysisSemantic proximity Read

Predictive Systems Biology Modeling: Unraveling Host Metabolic Disruptions and Potential Drug Targets in Acute Viral InfectionsSemantic proximity Read

Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral TargetSemantic proximity Read

Host metabolic reprogramming in response to SARS-Cov-2 infectionSemantic proximity Read

Integrated Human-Virus Metabolic Modelling Predicts Host-Based Antiviral Targets Against Chikungunya, Dengue and Zika VirusesSemantic proximity Read

Rapid discovery of antiviral targets through dimensionality reduction of genome-scale metabolic modelsSemantic proximity Read

Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target.Semantic proximity Read